Amarin Corp. PLC’s 28-month bid to block imports of some omega-3 ingredients in litigation that questioned the Food and Drug Administration’s oversight of the entire dietary supplement industry ended with a single line posted by the US Supreme Court.
The High Court on 9 December included its decision on Amarin’s ’s petition for a writ of certiorari among the...








